MindMaze Therapeutics Unveils Promising Home-Based Rehab Outcomes

MindMaze Therapeutics has reported encouraging results from a multi-site program showcasing its home-based rehab solutions. Conducted with Vibra Healthcare, the study featured at the American Congress of Rehabilitation Medicine, highlighted a threefold increase in rehabilitation training dose, with 84% of the activities performed independently by patients. Significant improvements were noted in functional metrics such as independence, balance, mobility, and cognition.

The findings support the strategy to transition high-dose neurorehabilitation into home settings, a move aligned with their forthcoming product, MindMotion Lite. This tablet-based solution aims to facilitate easier deployment of MindMotion GO activities at home, thereby broadening access to quality neurotherapeutics and bridging care gaps post-clinic discharge.